Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

long-term condition

- PMLiVE

ADA: Sanofi shifts focus to embrace integration in diabetes

Pascale Witz unveils company's ambitions at ADA conference

- PMLiVE

Haemophilia Society launches UK awareness drive

Charity tackles poor understanding of bleeding disorder

FDA shares new #socialmedia guidance

Latest recommendations cover Twitter, paid search links and correcting misinformation

Gilead Sciences

Sovaldi stumbles as NICE assesses hep C drug’s price

Gilead must provide much more cost-effectiveness information

- PMLiVE

Merck KGaA drops Ono-partnered multiple sclerosis drug

Decides phase III candidate ceralifimod isn't worth its continued investment

- PMLiVE

UCB taps EU for €75m in R&D funding

Agrees innovative risk-sharing finance deal with European Investment Bank

- PMLiVE

ADA: Merck launches registry for type 2 diabetes

Will collect information from 20,000 patients across four countries

- PMLiVE

ADA: Empagliflozin overcomes FDA concerns

Boehringer and Lilly expect decision on diabetes treatment by end of 2014

- PMLiVE

Counting value under the US Sunshine Act

International in scope, the implication of the transparency legislation are anything but clear

- PMLiVE

Fishawack appoints John Handley as new chairman

He joins to support UK group's acquisition plans

- PMLiVE

Designing unique patient solutions in rare disease

Living with any chronic health condition can be demanding, but rare diseases bring a unique set of challenges for patients.

As Apple’s HealthKit is to iOS so could Google Fit be to Android?

Google said to be readying health data service of its own

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links